Cancer Diagnosis, Risk Assessment and Prediction of Therapeutic Response by Means of DNA Methylation Markers

by Fiegl, Heidi, Elmasry, Karim
Published 2007

Reduced mRNA expression levels of NFE2L2 are associated with poor outcome in breast cancer patients

by Wolf, Barbara, Goebel, Georg, Hackl, Hubert, Fiegl, Heidi
Published in BMC Cancer (2016)

The impact of sample storage time on estimates of association in biomarker discovery studies

by Kugler, Karl G, Hackl, Werner O, Mueller, Laurin AJ, Fiegl, Heidi, Graber, Armin, Pfeiffer, Ruth M
Published 2011

Clinical Relevance of CDH1 and CDH13 DNA-Methylation in Serum of Cervical Cancer Patients

by Abudukadeer, Abida, Bakry, Rania, Goebel, Georg, Mutz-Dehbalaie, Irene, Widschwendter, Andreas, Bonn, Günther K., Fiegl, Heidi
Published 2012

Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation

by Teschendorff, Andrew E, Jones, Allison, Fiegl, Heidi, Sargent, Alexandra, Zhuang, Joanna J, Kitchener, Henry C, Widschwendter, Martin
Published 2012

Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance

by Brennan, Donal J, Hackethal, Andreas, Mann, Kristy P, Mutz-Dehbalaie, Irene, Fiegl, Heidi, Marth, Christian, Obermair, Andreas
Published in BMC Cancer (2015)

Evaluation of folate receptor 1 (FOLR1) mRNA expression, its specific promoter methylation and global DNA hypomethylation in type I and type II ovarian cancers

by Notaro, Sara, Reimer, Daniel, Fiegl, Heidi, Schmid, Gabriel, Wiedemair, Annamarie, Rössler, Julia, Marth, Christian, Zeimet, Alain Gustave
Published in BMC Cancer (2016)

Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer

by Leitner, Katharina, Tsibulak, Irina, Wieser, Verena, Knoll, Katharina, Reimer, Daniel, Marth, Christian, Fiegl, Heidi, Zeimet, Alain G.
Published in Sci Rep (2020)

Long non-coding RNAs as targets for cytosine methylation

by Amort, Thomas, Soulière, Marie F., Wille, Alexandra, Jia, Xi-Yu, Fiegl, Heidi, Wörle, Hildegard, Micura, Ronald, Lusser, Alexandra
Published 2013

Epigenotyping in Peripheral Blood Cell DNA and Breast Cancer Risk: A Proof of Principle Study

by Widschwendter, Martin, Apostolidou, Sophia, Raum, Elke, Rothenbacher, Dietrich, Fiegl, Heidi, Menon, Usha, Stegmaier, Christa, Jacobs, Ian J., Brenner, Hermann
Published 2008

Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens

by Schirmer, Uwe, Fiegl, Heidi, Pfeifer, Marco, Zeimet, Alain G, Müller-Holzner, Elisabeth, Bode, Peter K, Tischler, Verena, Altevogt, Peter
Published 2013

High prevalence of side population in human cancer cell lines

by Boesch, Maximilian, Zeimet, Alain G., Fiegl, Heidi, Wolf, Barbara, Huber, Julia, Klocker, Helmut, Gastl, Guenther, Sopper, Sieghart, Wolf, Dominik
Published in Oncoscience (2016)

Clinical impact of L1CAM expression measured on the transcriptome level in ovarian cancer

by Azim, Samira Abdel, Duggan-Peer, Michaela, Sprung, Susanne, Reimer, Daniel, Fiegl, Heidi, Soleiman, Afschin, Marth, Christian, Zeimet, Alain G.
Published in Oncotarget (2016)

Correction to: Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens

by Schirmer, Uwe, Fiegl, Heidi, Pfeifer, Marco, Zeimet, Alain G., Müller-Holzner, Elisabeth, Bode, Peter K., Tischler, Verena, Altevogt, Peter
Published in BMC Cancer (2018)

Evaluating L1CAM expression in human endometrial cancer using qRT-PCR

by Notaro, Sara, Reimer, Daniel, Duggan-Peer, Michaela, Fiegl, Heidi, Wiedermair, Annamarie, Rössler, Julia, Altevogt, Peter, Marth, Christian, Zeimet, Alain Gustave
Published in Oncotarget (2016)

Evaluation of Vav3.1 as prognostic marker in endometrial cancer

by Boesch, Maximilian, Sopper, Sieghart, Marth, Christian, Fiegl, Heidi, Wiedemair, Annemarie, Rössler, Julia, Hatina, Jiri, Wolf, Dominik, Reimer, Daniel, Zeimet, Alain G.
Published in J Cancer Res Clin Oncol (2018)

High RIG‐I expression in ovarian cancer associates with an immune‐escape signature and poor clinical outcome

by Wolf, Dominik, Fiegl, Heidi, Zeimet, Alain G., Wieser, Verena, Marth, Christian, Sprung, Susanne, Sopper, Sieghart, Hartmann, Gunther, Reimer, Daniel, Boesch, Maximilian
Published in Int J Cancer (2019)

DNA ploidy, nuclear size, proliferation index and DNA-hypomethylation in ovarian cancer

by Zeimet, Alain G., Fiegl, Heidi, Goebel, Georg, Kopp, Francis, Allasia, Claude, Reimer, Daniel, Steppan, Ilona, Mueller-Holzner, Elisabeth, Ehrlich, Melanie, Marth, Christian
Published 2011

FOXO3/FKHRL1 is activated by 5-aza-2-deoxycytidine and induces silenced caspase-8 in neuroblastoma

by Geiger, Kathrin, Hagenbuchner, Judith, Rupp, Martina, Fiegl, Heidi, Sergi, Consolato, Meister, Bernhard, Kiechl-Kohlendorfer, Ursula, Müller, Thomas, Ausserlechner, Michael J., Obexer, Petra
Published 2012

Detection of soluble EpCAM (sEpCAM) in malignant ascites predicts poor overall survival in patients treated with catumaxomab

by Seeber, Andreas, Braicu, Ioana, Untergasser, Gerold, Nassir, Mani, Fong, Dominic, Botta, Laura, Gastl, Guenther, Fiegl, Heidi, Zeimet, Alain, Sehouli, Jalid, Spizzo, Gilbert
Published in Oncotarget (2015)